{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:02:55Z","timestamp":1793502175223,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"am","delay-in-days":329,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jmmc-online.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Molecular and Cellular Cardiology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/j.yjmcc.2019.06.013","type":"journal-article","created":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T03:46:05Z","timestamp":1561002365000},"page":"199-208","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"C","title":["Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy"],"prefix":"10.1016","volume":"133","author":[{"given":"Alexey V.","family":"Dvornikov","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingmin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingchun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tai","family":"Le","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4197-7208","authenticated-orcid":false,"given":"Hung","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0005","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2017.06.008","article-title":"Heterogeneity in a large pedigree with Danon disease: implications for pathogenesis and management","volume":"123","author":"Roos","year":"2018","journal-title":"Mol. Genet. Metab."},{"issue":"12","key":"10.1016\/j.yjmcc.2019.06.013_bb0010","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1001\/jama.2009.371","article-title":"Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy","volume":"301","author":"Maron","year":"2009","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1212\/WNL.31.1.51","article-title":"Lysosomal glycogen storage disease with normal acid maltase","volume":"31","author":"Danon","year":"1981","journal-title":"Neurology"},{"issue":"5","key":"10.1016\/j.yjmcc.2019.06.013_bb0020","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1161\/CIRCHEARTFAILURE.114.001105","article-title":"Danon disease: clinical features, evaluation, and management","volume":"7","author":"D'Souza","year":"2014","journal-title":"Circ. Heart Fail."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.06.013_bb0025","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s00401-015-1385-4","article-title":"Danon disease: a phenotypic expression of LAMP-2 deficiency","volume":"129","author":"Endo","year":"2015","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.yjmcc.2019.06.013_bb0030","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1016\/j.ophtha.2006.02.030","article-title":"Ophthalmic manifestations of Danon disease","volume":"113","author":"Prall","year":"2006","journal-title":"Ophthalmology"},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0035","series-title":"Hurst's the Heart","author":"Fuster","year":"2017"},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0040","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1146\/annurev.genom.6.080604.162132","article-title":"The genetic basis for cardiac remodeling","volume":"6","author":"Ahmad","year":"2005","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"6273","key":"10.1016\/j.yjmcc.2019.06.013_bb0045","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1126\/science.aad3456","article-title":"A small-molecule inhibitor of sarcomere contractility suppresses hypertrophic cardiomyopathy in mice","volume":"351","author":"Green","year":"2016","journal-title":"Science"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0050","doi-asserted-by":"crossref","first-page":"e2565","DOI":"10.1038\/cddis.2016.475","article-title":"Autophagy dysregulation in Danon disease","volume":"8","author":"Nascimbeni","year":"2017","journal-title":"Cell Death Dis."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0055","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1073\/pnas.1808618116","article-title":"LAMP-2B regulates human cardiomyocyte function by mediating autophagosome-lysosome fusion","volume":"116","author":"Chi","year":"2019","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0060","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.bbrc.2015.03.025","article-title":"An RNautophagy\/DNautophagy receptor, LAMP2C, possesses an arginine-rich motif that mediates RNA\/DNA-binding","volume":"460","author":"Fujiwara","year":"2015","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6798","key":"10.1016\/j.yjmcc.2019.06.013_bb0065","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/35022604","article-title":"Primary LAMP-2 deficiency causes X-linked vacuolar cardiomyopathy and myopathy (Danon disease)","volume":"406","author":"Nishino","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0070","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1006\/bbrc.1995.2528","article-title":"An alternative spliced form of the human lysosome-associated membrane protein-2 gene is expressed in a tissue-specific manner","volume":"215","author":"Konecki","year":"1995","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"6798","key":"10.1016\/j.yjmcc.2019.06.013_bb0075","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1038\/35022595","article-title":"Accumulation of autophagic vacuoles and cardiomyopathy in LAMP-2-deficient mice","volume":"406","author":"Tanaka","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0080","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.yjmcc.2017.05.007","article-title":"Impaired mitophagy facilitates mitochondrial damage in Danon disease","volume":"108","author":"Hashem","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.06.013_bb0085","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ncb2204","article-title":"Lysosomal positioning coordinates cellular nutrient responses","volume":"13","author":"Korolchuk","year":"2011","journal-title":"Nat. Cell Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0090","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.molcel.2014.11.013","article-title":"mTORC1 phosphorylates UVRAG to negatively regulate autophagosome and endosome maturation","volume":"57","author":"Kim","year":"2015","journal-title":"Mol. Cell"},{"issue":"6032","key":"10.1016\/j.yjmcc.2019.06.013_bb0095","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1126\/science.1205407","article-title":"Spatial coupling of mTOR and autophagy augments secretory phenotypes","volume":"332","author":"Narita","year":"2011","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.yjmcc.2019.06.013_bb0100","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1172\/JCI44972","article-title":"Rapamycin reverses hypertrophic cardiomyopathy in a mouse model of LEOPARD syndrome-associated PTPN11 mutation","volume":"121","author":"Marin","year":"2011","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.06.013_bb0105","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1161\/CIRCRESAHA.117.311147","article-title":"New insights into the role of mTOR signaling in the cardiovascular system","volume":"122","author":"Sciarretta","year":"2018","journal-title":"Circ. Res."},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0110","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.pbiomolbio.2018.05.013","article-title":"Phenotyping cardiomyopathy in adult zebrafish","volume":"138","author":"Dvornikov","year":"2018","journal-title":"Prog. Biophys. Mol. Biol."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0115","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1161\/CIRCGENETICS.114.000702","article-title":"Cardiac transcriptome and dilated cardiomyopathy genes in zebrafish","volume":"8","author":"Shih","year":"2015","journal-title":"Circ. Cardiovasc. Genet."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0120","doi-asserted-by":"crossref","first-page":"142","DOI":"10.4161\/auto.8.1.18536","article-title":"TOR-autophagy signaling in adult zebrafish models of cardiomyopathy","volume":"8","author":"Ding","year":"2012","journal-title":"Autophagy"},{"issue":"14","key":"10.1016\/j.yjmcc.2019.06.013_bb0125","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88797","article-title":"A modifier screen identifies DNAJB6 as a cardiomyopathy susceptibility gene","volume":"1","author":"Ding","year":"2016","journal-title":"JCI Insight"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0130","doi-asserted-by":"crossref","first-page":"8603","DOI":"10.1038\/s41598-017-09152-x","article-title":"Automated segmentation of light-sheet fluorescent imaging to characterize experimental doxorubicin-induced cardiac injury and repair","volume":"7","author":"Packard","year":"2017","journal-title":"Sci. Rep."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.06.013_bb0135","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0006596","article-title":"Cardiac hypertrophy involves both myocyte hypertrophy and hyperplasia in anemic zebrafish","volume":"4","author":"Sun","year":"2009","journal-title":"PLoS ONE"},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0140","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.yjmcc.2017.05.011","article-title":"Induction of cardiac dysfunction in developing and adult zebrafish by chronic isoproterenol stimulation","volume":"108","author":"Kossack","year":"2017","journal-title":"J. Mol. Cell. Cardiol."},{"issue":"3","key":"10.1016\/j.yjmcc.2019.06.013_bb0145","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4161\/cc.11.3.19164","article-title":"Target of rapamcyin (TOR)-based therapeutics for cardiomyopathy: insights from zebrafish genetics","volume":"11","author":"Ding","year":"2012","journal-title":"Cell Cycle"},{"issue":"6","key":"10.1016\/j.yjmcc.2019.06.013_bb0150","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/CIRCRESAHA.111.248260","article-title":"Haploinsufficiency of target of rapamycin attenuates cardiomyopathies in adult zebrafish","volume":"109","author":"Ding","year":"2011","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0155","first-page":"63","article-title":"Standardized echocardiographic assessment of cardiac function in normal adult zebrafish and heart disease models","volume":"10","author":"Wang","year":"2017","journal-title":"Dis. Model. Mech."},{"issue":"9","key":"10.1016\/j.yjmcc.2019.06.013_bb0160","article-title":"A Langendorff-like system to quantify cardiac pump function in adult zebrafish","volume":"11","author":"Dvornikov","year":"2018","journal-title":"Dis. Model. Mech."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.06.013_bb0165","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1039\/C4IB00052H","article-title":"Wearable multi-channel microelectrode membranes for elucidating electrophysiological phenotypes of injured myocardium","volume":"6","author":"Cao","year":"2014","journal-title":"Integr. Biol."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.06.013_bb0170","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nprot.2016.049","article-title":"Explant culture of adult zebrafish hearts for epicardial regeneration studies","volume":"11","author":"Cao","year":"2016","journal-title":"Nat. Protoc."},{"issue":"11","key":"10.1016\/j.yjmcc.2019.06.013_bb0175","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1109\/JSEN.2019.2897789","article-title":"Acquisition, processing and analysis of electrocardiogram in awake zebrafish","volume":"19","author":"Le","year":"2019","journal-title":"IEEE Sensors"},{"issue":"9","key":"10.1016\/j.yjmcc.2019.06.013_bb0180","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1113\/jphysiol.2014.270678","article-title":"Novel approaches to determine contractile function of the isolated adult zebrafish ventricular cardiac myocyte","volume":"592","author":"Dvornikov","year":"2014","journal-title":"J. Physiol. Lond."},{"issue":"Pt 2","key":"10.1016\/j.yjmcc.2019.06.013_bb0185","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1113\/jphysiol.2007.138693","article-title":"Impact of temperature on cross-bridge cycling kinetics in rat myocardium","volume":"584","author":"de Tombe","year":"2007","journal-title":"J. Physiol."},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0190","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/978-1-59745-157-4_4","article-title":"LC3 and autophagy","volume":"445","author":"Tanida","year":"2008","journal-title":"Methods Mol. Biol."},{"issue":"11","key":"10.1016\/j.yjmcc.2019.06.013_bb0195","doi-asserted-by":"crossref","first-page":"H1936","DOI":"10.1152\/ajpheart.00327.2015","article-title":"A dilated cardiomyopathy mutation blunts adrenergic response and induces contractile dysfunction under chronic angiotensin II stress","volume":"309","author":"Wilkinson","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2019.06.013_bb0200","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1073\/pnas.85.9.3265","article-title":"Effect of Ca2+ on cross-bridge turnover kinetics in skinned single rabbit psoas fibers: implications for regulation of muscle contraction","volume":"85","author":"Brenner","year":"1988","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"15","key":"10.1016\/j.yjmcc.2019.06.013_bb0205","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1113\/jphysiol.2008.155952","article-title":"The familial hypertrophic cardiomyopathy-associated myosin mutation R403Q accelerates tension generation and relaxation of human cardiac myofibrils","volume":"586","author":"Belus","year":"2008","journal-title":"J. Physiol."},{"issue":"9","key":"10.1016\/j.yjmcc.2019.06.013_bb0210","doi-asserted-by":"crossref","first-page":"H1086","DOI":"10.1152\/ajpheart.00501.2014","article-title":"Elevated Ca2+ transients and increased myofibrillar power generation cause cardiac hypercontractility in a model of Noonan syndrome with multiple lentigines","volume":"308","author":"Clay","year":"2015","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0215","doi-asserted-by":"crossref","first-page":"315","DOI":"10.3389\/fphys.2014.00315","article-title":"Investigating the role of uncoupling of troponin I phosphorylation from changes in myofibrillar Ca(2+)-sensitivity in the pathogenesis of cardiomyopathy","volume":"5","author":"Messer","year":"2014","journal-title":"Front. Physiol."},{"issue":"8","key":"10.1016\/j.yjmcc.2019.06.013_bb0220","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.arcmed.2018.12.008","article-title":"Protein kinase a as a promising target for heart failure drug development","volume":"49","author":"Saad","year":"2018","journal-title":"Arch. Med. Res."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.06.013_bb0225","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.gep.2009.02.001","article-title":"The molecular structures and expression patterns of zebrafish troponin I genes","volume":"9","author":"Fu","year":"2009","journal-title":"Gene Expr. Patterns"},{"key":"10.1016\/j.yjmcc.2019.06.013_bb0230","first-page":"427","article-title":"The dynamic nature of hypertrophic and fibrotic remodeling of the fish ventricle","volume":"6","author":"Keen","year":"2015","journal-title":"Front. Physiol."},{"issue":"5","key":"10.1016\/j.yjmcc.2019.06.013_bb0235","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/j.cell.2016.04.002","article-title":"A tension-based model distinguishes hypertrophic versus dilated cardiomyopathy","volume":"165","author":"Davis","year":"2016","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0240","doi-asserted-by":"crossref","first-page":"H284","DOI":"10.1152\/ajpheart.00128.2007","article-title":"Hypertrophic and dilated cardiomyopathy mutations differentially affect the molecular force generation of mouse alpha-cardiac myosin in the laser trap assay","volume":"293","author":"Debold","year":"2007","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"11","key":"10.1016\/j.yjmcc.2019.06.013_bb0245","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1016\/j.celrep.2016.11.040","article-title":"Early-onset hypertrophic cardiomyopathy mutations significantly increase the velocity, force, and actin-activated ATPase activity of human beta-cardiac myosin","volume":"17","author":"Adhikari","year":"2016","journal-title":"Cell Rep."},{"issue":"2","key":"10.1016\/j.yjmcc.2019.06.013_bb0250","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1113\/JP271290","article-title":"Contractile properties of developing human fetal cardiac muscle","volume":"594","author":"Racca","year":"2016","journal-title":"J. Physiol."},{"issue":"4","key":"10.1016\/j.yjmcc.2019.06.013_bb0255","first-page":"191","article-title":"Clinical implications of left atrial enlargement: a review","volume":"9","author":"Patel","year":"2009","journal-title":"Ochsner J."},{"issue":"1","key":"10.1016\/j.yjmcc.2019.06.013_bb0260","doi-asserted-by":"crossref","first-page":"H231","DOI":"10.1152\/ajpheart.00665.2011","article-title":"The PTPN11 loss-of-function mutation Q510E-Shp2 causes hypertrophic cardiomyopathy by dysregulating mTOR signaling","volume":"302","author":"Schramm","year":"2012","journal-title":"Am. J. Physiol. Heart Circ. Physiol."}],"container-title":["Journal of Molecular and Cellular Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819301348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022282819301348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,19]],"date-time":"2025-09-19T20:28:43Z","timestamp":1758313723000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022282819301348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8]]},"references-count":52,"alternative-id":["S0022282819301348"],"URL":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.06.013","relation":{},"ISSN":["0022-2828"],"issn-type":[{"value":"0022-2828","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotyping an adult zebrafish lamp2 cardiomyopathy model identifies mTOR inhibition as a candidate therapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Molecular and Cellular Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yjmcc.2019.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}